COVID-19 and kidney diseases: A meta-analysis of clinical outcomes

Fateme Shamekhi  Amiri

doi:10.31450/ukrjnd.3(71).2021.07

Fateme Shamekhi Amiri Imam Khomeini Hospital Complex, National Tehran Medical College, National Tehran of University Medical Sciences https://orcid.org/0000-0002-5686-273X

DOI: https://doi.org/10.31450/ukrjnd.3(71).2021.07

Keywords: COVID-19 nephropathy, acute kidney injury, acute kidney disease, chronic kidney disease.

Abstract

Abstract. Novel coronavirus 2019 (COVID-19) is a highly infectious disease that causes multiorgan failure and a high mortality rate. The present study aimed to investigate the association between COVID-19 infection and kidney dysfunction.
Methods. In this meta-analysis study, 68 patients with kidney dysfunction and COVID-19 infection were analysed. Clinical features, laboratory data at initial presentation, management and, outcomes were collected. Risk of acute kidney injury (AKI), acute kidney disease (AKD) and chronic kidney disease (CKD) progression to kidney replacement therapy and graft loss were primary outcomes in this study.
Results. The average age of patients at the time of diagnosis in COVID-19 nephropathy was 52.04 ± 14.42 years. There were ICU admission in 10/68 (14.7%) patients with COVID-19 nephropathy. There were a need for mechanical ventilation in 13/68 (19.1%) patients; 15/68 (22%) patients died during hospital course or post-discharge. There were AKI in 4/68 (5.8%) patients with COVID-19 nephropathy and AKD found in 14/68 (20.5%) patients with COVID-19 nephropathy during the follow-up. The median and interquartile range of SCr during the follow-up period was assessed at 1.74 mg/dl and 1.18 (Q3-Q1=2.73-1.55), respectively. The effect size of COVID-19 on AKI and AKD was assessed 0 and 0.003 using Cohen᾽s-d test. Eventually, 10 of 68 (14.7%) patients with COVID-19 nephropathy stayed on hemodialysis during the follow-up period and one of them remained on RRT but its type was not characterized. There were a total of 36/68 (52.9%) kidney transplant recipients and 10/36 (27.7%) of them developed AKI due to acute rejection. The effect size of elevated IL-6 on decreased estimated glomerular filtration rate (eGFR) in COVID-19 nephropathy was assessed 0.656 (medium effect size).
Conclusion. The COVID-19 had a trivial (small) effect on eGFR declining. Future clinical research is required for investigating novel unknown findings in COVID-19 nephropathy.

Downloads

Download data is not yet available.

References

l-Ani AH, Prentice RE, Rentsch CA, Johnson D, Ardalan Z, Heerasing N, et al. Review article: prevention, diagnosis and management of COVID-19 in the IBD patient. Aliment Pharmacol Ther 2020;52(1): 4-72. doi: 10. 1111/apt.15779.

Samina M, Tabish SA, Mufti SA, Ajaz M, Rehana K, Panditha K, et al. Role of Hospital in Pandemic: Our Experience. JIMSA 2012; 25 (3): 201-204.

Chhikara BS, Rathi B, Singh J, Poonam. Corona virus SARS-CoV-2 disease COVID-19: Infection, prevention and clinical advances of the prospective chemical drug therapeutics. Chem Biol Let 2020; 7(1): 63-72.

McIntosh K. Coronavirus disease 2019 (COVID-19): Epidemiology, virology, and prevention. UpToDate, 2020 May [cited 2020 June 4]: 1-31 p. Available at: https://www.uptodate.com/contents/covid-19-epidemiology-virology-and-prevention.

Tang H, Tian JB, Dong JW, Tang XT, Yan ZY, Zhao YY, et al. Serologic Detection of SARS-CoV-2 Infections in Hemodialysis Centers: A Multicenter Retrospective Study in Wuhan, China. Am J Kidney Dis. 2020 Oct;76(4):490-499.e1. doi: 10.1053/j.ajkd.2020.06.008.

Tang B, Li S, Xiong Y, Tian M, Yu J, Xu L, Zhang L, Li Z, Ma J, Wen F, Feng Z, Liang X, Shi W, Liu S. COVID-19 Pneumonia in a Hemodialysis Patient. Kidney Med. 2020;2(3):354-358. doi: 10.1016/j.xkme.2020.03.001.

Fu D, Yang B, Xu J, Mao Z, Zhou C, Xue C. COVID-19 Infection in a Patient with End-Stage Kidney Disease. Nephron. 2020;144(5):245-247. doi: 10.1159/000507261.

Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, et al. A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease. Am J Nephrol. 2020;51(5):337-342. doi: 10.1159/000507417.

Huang J, Lin H, Wu Y, Fang Y, Kumar R, Chen G, et al. COVID-19 in post-transplantation patients -report of two cases. Am J Transplant 2020;20 (7):1879-1881. doi:10.1111/ajt.1589.

Seminari E, Colaneri M, Sambo M, Gallazzi I, Di Matteo A, Roda S, Bruno R; COVID19 IRCCS San Matteo Pavia Task Force. SARS Cov-2 infection in a renal-transplanted patient: A case report. Am J Transplant. 2020;20(7):1882-1884. doi: 10.1111/ajt.15902.

Chen S, Yin Q, Shi H, Du D, Chang S, Ni L, et al. A familial cluster, including a kidney transplant recipient, of Coronavirus Disease 2019 (COVID-19) in Wuhan, China. Am J Transplant 2020; 20 (7): 1869-1874. doi:10.1111/ajt.15903.

Bussalino E, De Maria A, Russo R, Paoletti E. Immunosuppressive therapy maintenance in a kidney transplant recipient with SARS-CoV-2 pneumonia: A case report. Am J Transplant. 2020;20(7):1922-1924. doi: 10.1111/ajt.15920.

Fontana F, Alfano G, Mori G, Amurri A, Tei L, Ballestri M, et al. COVID-19 pneumonia in a kidney transplant recipient successfully treated with tocilizumab and hydroxychloroquine. Am J Transplant. 2020 Jul;20(7):1902-1906. doi: 10.1111/ajt.15935.

Kim Y, Kwon O, Paek JH, Park WY, Jin K, Hyun M, et al. Two distinct cases with COVID-19 in kidney transplant recipients. Am J Transplant. 2020 Aug;20(8):2269-2275. doi: 10.1111/ajt.15947.

Banerjee D, Popoola J, Shah S, Ster IC, Quan V, Phanish M. COVID-19 infection in kidney transplant recipients. Kidney Int. 2020;97(6):1076-1082. doi: 10.1016/j.kint.2020.03.018.

Guillen E, Pineiro GJ, Revuelta I, Rodriguez D, Bodro M, Moreno A, Campistol JM, Diekmann F, Ventura-Aguiar P. Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? Am J Transplant. 2020;20(7):1875-1878. doi: 10.1111/ajt.15874.

Karami P, Naghavi M, Feyzi A, Aghamohammadi M, Novin MS, Mobaien A, Qorbanisani M, Karami A, Norooznezhad AH. WITHDRAWN: Mortality of a pregnant patient diagnosed with COVID-19: A case report with clinical, radiological, and histopathological findings. Travel Med Infect Dis. 2020 Apr 11:101665. doi: 10.1016/j.tmaid.2020.101665.

Kissling S, Rotman S, Gerber C, et al. Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 2020;98(1):228-231. doi:10.1016/j.kint.2020.04.006

Sharifi-Razavi A, Karimi N, Rouhani N. COVID-19 and intracerebral haemorrhage: causative or coincidental? New Microbes New Infect. 2020 Mar 27;35:100669. doi: 10.1016/j.nmni.2020.100669.

Zhu L, Gong N, Liu B, et al. Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China. Eur Urol. 2020;77(6):748-754. doi:10.1016/j.eururo.2020.03.039.

Marx D, Moulin B, Fafi-Kremer S, Benotmane I, Gautier G, Perrin P, Caillard S. First case of COVID-19 in a kidney transplant recipient treated with belatacept. Am J Transplant. 2020 Jul;20(7):1944-1946. doi: 10.1111/ajt.15919.